Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Glucagon-like Receptor Agonists

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same authorSame journal

Transcutaneous CO<sub>2</sub> Therapy Improves Tissue Oxygenation, Ulcer Healing and Pain in Recurrent Hard-to-Heal Diabetic Foot Ulcers: A Randomized Controlled Trial.

The international journal of lower extremity wounds·2026

Same authorSame journal

Pacinian Corpuscle Distribution, Density, and Morphology of the Adult Human Foot in Health and Diabetes: A Scoping Review.

The international journal of lower extremity wounds·2026

Same author

SGLT-2 Inhibitors and Lower-limb Amputations in Diabetes: A Misunderstood Relationship? Insights from a Retrospective Study.

The international journal of lower extremity wounds·2026

Same author

Treatment-induced neuropathy of diabetes: A comprehensive literature review.

Diabetes research and clinical practice·2026

Same author

Glucagon-Like Peptide-1 Receptor Agonists: Their Therapeutic Potential in Cystic Fibrosis.

Advances in therapy·2026

Same author

Glucagon-Like Peptide-1 Receptor Agonists: Their Potential Role in Prediabetes.

Diabetes therapy : research, treatment and education of diabetes and related disorders·2026

Search research articles

Related Experiment Video

Updated: Jan 12, 2026

Using a Split-belt Treadmill to Evaluate Generalization of Human Locomotor Adaptation

Using a Split-belt Treadmill to Evaluate Generalization of Human Locomotor Adaptation

Published on: August 23, 2017

Walking Further with GLP-1RAs: Lessons from the STRIDE Trial

Dimitrios Pantazopoulos¹, Stella Papachristou², Prashanth R J Vas^2,3

¹Diabetes Centre-Diabetic Foot Clinic, Second Department of Internal Medicine, Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupolis, Greece.

The International Journal of Lower Extremity Wounds

|October 31, 2025

Summary

No abstract available in PubMed .

More Related Videos

Home-Based Monitor for Gait and Activity Analysis

Home-Based Monitor for Gait and Activity Analysis

Published on: August 8, 2019

Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease

Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease

Published on: January 18, 2021

Related Experiment Videos

Last Updated: Jan 12, 2026

Using a Split-belt Treadmill to Evaluate Generalization of Human Locomotor Adaptation

Using a Split-belt Treadmill to Evaluate Generalization of Human Locomotor Adaptation

Published on: August 23, 2017

Home-Based Monitor for Gait and Activity Analysis

Home-Based Monitor for Gait and Activity Analysis

Published on: August 8, 2019

Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease

Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease

Published on: January 18, 2021